475 related articles for article (PubMed ID: 4281113)
1. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
Thorsen S; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
[No Abstract] [Full Text] [Related]
2. Reversible and irreversible alterations of human plasminogen indicated by changes in susceptibility to plasminogen activators and in response to epsilon-aminocaproic acid.
Thorsen S; Kok P; Astrup T
Thromb Diath Haemorrh; 1974 Dec; 32(2-3):325-40. PubMed ID: 4450189
[No Abstract] [Full Text] [Related]
3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
4. Human urokinase and porcine tissue plasminogen activator. A comparative study of the mechanism of fibrinolysis, and the effect of natural proteinase inhibitors and omega-aminocarboxylic acids.
Thorsen S
Dan Med Bull; 1977 Oct; 24(5):189-206. PubMed ID: 908205
[No Abstract] [Full Text] [Related]
5. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic agents and their effects on the haemostatic system.
Kluft C
Klin Wochenschr; 1988; 66 Suppl 12():50-4. PubMed ID: 2964542
[TBL] [Abstract][Full Text] [Related]
7. [Effects of epsilon-aminocaproic acid, amben and kontrikal on fibrinolysis due to tissue-type plasminogen activator from the pig heart].
Shimonaeva EE; Andreenko GV; Alieva NI
Farmakol Toksikol; 1986; 49(4):35-8. PubMed ID: 2428660
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte-plasma interaction in fibrinolysis. A new dimension in the action of urokinase.
Moroz LA; Sniderman AD; Marpole DG
N Engl J Med; 1979 Nov; 301(20):1100-4. PubMed ID: 158709
[No Abstract] [Full Text] [Related]
9. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
10. Proceedings: Fibrinolysis versus fibrinogenolysis: the specificity of human vascular activator (VA) as compared to urokinase (UK) and streptokinase (SK).
Lipinski B; Gurewich V; Hyde E
Thromb Diath Haemorrh; 1975 Sep; 34(1):351. PubMed ID: 1188799
[No Abstract] [Full Text] [Related]
11. In vitro potentiation of urokinase-activated lysis of human fibrin clots.
Singh K; Vézina C
J Med; 1974; 5(6):297-302. PubMed ID: 4528600
[No Abstract] [Full Text] [Related]
12. [Changes in the components of the animal fibrinolytic system induced by the action of physiological activators and enzymes of fungal origin].
Andreenko GV; Serebriakova TN; Shimonaeva EE; Liutova LV; Karabasova MA
Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (3):51-4. PubMed ID: 6342687
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical and histochemical investigations on in vivo thrombolysis with urokinase in rabbits.
Hisano S; Sueishi K; Ishii Y; Tanaka K
Thromb Haemost; 1979 Jun; 41(4):796-803. PubMed ID: 483251
[TBL] [Abstract][Full Text] [Related]
15. [In vitro measurement of fibrinolysis by urokinase].
Senf L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):819-21. PubMed ID: 6176506
[TBL] [Abstract][Full Text] [Related]
16. Differentiation between plasminogen activators by means of epsilon-aminocaproic acid.
Kok P; Astrup T
Thromb Diath Haemorrh; 1972 Feb; 27(1):77-87. PubMed ID: 4260740
[No Abstract] [Full Text] [Related]
17. Properties of chimeric (tissue-type/urokinase-type) plasminogen activators obtained by fusion at the plasmin cleavage site.
Colucci M; Cavallo LG; Agnelli G; Mele A; Bürgi R; Heim J; Semeraro N
Thromb Haemost; 1993 May; 69(5):466-72. PubMed ID: 8391727
[TBL] [Abstract][Full Text] [Related]
18. [Studies on coagulation and fibrinolysis. III. Urokinase activated fibrinolysodynamicogram].
Hu YM; Xue H; Wang KQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Jun; 4(3):133-6. PubMed ID: 6215134
[No Abstract] [Full Text] [Related]
19. Differences in the reactivities of human urokinase and the porcine tissue plasminogen activator.
Thorsen S; Astrup T
Haemostasis; 1976; 5(5):295-305. PubMed ID: 14058
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
Godal HC; Theodor I
Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
[No Abstract] [Full Text] [Related]
[Next] [New Search]
